ABCL – AbCellera Biologics Inc.
Name : AbCellera Biologics Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $0.0000
EPSttm :
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
11.84
Margin Of Safety %
Put/Call OI Ratio
0.12
EPS Next Q Diff
-0.01
EPS Last/This Y
-0.09
EPS This/Next Y
0.01
Price
3.6
Target Price
8.33
Analyst Recom
1.25
Performance Q
52.97
Relative Volume
1.21
Beta
0.59
Ticker: ABCL
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | ABCL | 2.14 | 0.22 | 0.04 | 18853 |
| 2025-06-03 | ABCL | 2.31 | 0.22 | 0.07 | 19310 |
| 2025-06-04 | ABCL | 2.42 | 0.20 | 0.14 | 21145 |
| 2025-06-05 | ABCL | 2.36 | 0.19 | 0.09 | 22776 |
| 2025-06-06 | ABCL | 2.44 | 0.19 | 0.10 | 23553 |
| 2025-06-09 | ABCL | 2.52 | 0.19 | 0.00 | 23939 |
| 2025-06-10 | ABCL | 3.02 | 0.19 | 0.09 | 24079 |
| 2025-06-11 | ABCL | 3.22 | 0.16 | 0.05 | 29275 |
| 2025-06-12 | ABCL | 3.13 | 0.13 | 0.07 | 38612 |
| 2025-06-13 | ABCL | 3.2 | 0.13 | 0.17 | 39343 |
| 2025-06-16 | ABCL | 3.17 | 0.14 | 0.21 | 39374 |
| 2025-06-17 | ABCL | 3.11 | 0.14 | 0.09 | 40541 |
| 2025-06-18 | ABCL | 3.47 | 0.14 | 0.14 | 40480 |
| 2025-06-20 | ABCL | 3.4 | 0.15 | 0.12 | 41128 |
| 2025-06-23 | ABCL | 3.33 | 0.13 | 0.50 | 39609 |
| 2025-06-24 | ABCL | 3.67 | 0.14 | 0.05 | 40154 |
| 2025-06-25 | ABCL | 3.8 | 0.13 | 0.06 | 45026 |
| 2025-06-26 | ABCL | 3.72 | 0.12 | 0.02 | 48209 |
| 2025-06-27 | ABCL | 3.6 | 0.12 | 0.14 | 48839 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | ABCL | 2.14 | -21.8 | - | -0.65 |
| 2025-06-03 | ABCL | 2.31 | -21.8 | - | -0.65 |
| 2025-06-04 | ABCL | 2.42 | -21.8 | - | -0.65 |
| 2025-06-05 | ABCL | 2.37 | -21.8 | - | -0.65 |
| 2025-06-06 | ABCL | 2.44 | -21.8 | - | -0.65 |
| 2025-06-09 | ABCL | 2.51 | -21.8 | - | -0.65 |
| 2025-06-10 | ABCL | 3.02 | -21.8 | - | -0.65 |
| 2025-06-11 | ABCL | 3.23 | -21.8 | - | -0.65 |
| 2025-06-12 | ABCL | 3.15 | -21.8 | - | -0.65 |
| 2025-06-13 | ABCL | 3.21 | -21.8 | - | -0.65 |
| 2025-06-16 | ABCL | 3.17 | -21.8 | - | -0.65 |
| 2025-06-17 | ABCL | 3.12 | -21.8 | - | -0.65 |
| 2025-06-18 | ABCL | 3.47 | -21.8 | - | -0.65 |
| 2025-06-20 | ABCL | 3.41 | -21.8 | - | -0.65 |
| 2025-06-23 | ABCL | 3.33 | -21.8 | - | -0.65 |
| 2025-06-24 | ABCL | 3.67 | -21.8 | - | -0.65 |
| 2025-06-25 | ABCL | 3.79 | -21.8 | - | -0.65 |
| 2025-06-26 | ABCL | 3.73 | -21.8 | - | -0.65 |
| 2025-06-27 | ABCL | 3.60 | -21.8 | - | -0.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | ABCL | 0.00 | 12.74 | 10.05 |
| 2025-06-03 | ABCL | 0.00 | 12.74 | 10.05 |
| 2025-06-04 | ABCL | 0.00 | 12.74 | 10.05 |
| 2025-06-05 | ABCL | 0.00 | 12.74 | 10.05 |
| 2025-06-06 | ABCL | 0.00 | 12.74 | 10.05 |
| 2025-06-09 | ABCL | 0.00 | 12.74 | 10.05 |
| 2025-06-10 | ABCL | 0.00 | 12.74 | 10.05 |
| 2025-06-11 | ABCL | 0.00 | 12.74 | 10.20 |
| 2025-06-12 | ABCL | 0.00 | 12.74 | 10.20 |
| 2025-06-13 | ABCL | 0.00 | 12.74 | 10.20 |
| 2025-06-16 | ABCL | 0.00 | 12.74 | 10.20 |
| 2025-06-17 | ABCL | 0.00 | 12.74 | 10.20 |
| 2025-06-18 | ABCL | 0.00 | 12.74 | 10.20 |
| 2025-06-20 | ABCL | 0.00 | 12.74 | 10.20 |
| 2025-06-23 | ABCL | 0.00 | 12.81 | 10.20 |
| 2025-06-24 | ABCL | 0.00 | 12.81 | 10.20 |
| 2025-06-25 | ABCL | 0.00 | 12.81 | 10.20 |
| 2025-06-26 | ABCL | 0.00 | 12.81 | 11.84 |
| 2025-06-27 | ABCL | 0.00 | 12.81 | 11.84 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL
589 360 ]
Last Quarter Act. EPS
-0.15
Avg. EPS Est. Current Quarter
-0.16
Avg. EPS Est. Next Quarter
-0.16
Insider Transactions
Institutional Transactions
12.81
Beta
0.59
Average Sales Estimate Current Quarter
7
Average Sales Estimate Next Quarter
7
Fair Value
Quality Score
24
Growth Score
34
Sentiment Score
84
Actual DrawDown %
95
Max Drawdown 5-Year %
Target Price
8.33
P/E
Forward P/E
PEG
P/S
46.61
P/B
1.05
P/Free Cash Flow
EPS
-0.57
Average EPS Est. Cur. Y
-0.65
EPS Next Y. (Est.)
-0.63
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-726.23
Relative Volume
1.21
Return on Equity vs Sector %
-40.3
Return on Equity vs Industry %
-22.5
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL
589 450 ]
AbCellera Biologics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 596
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today
news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance
stock history ABCL – AbCellera Biologics Inc. invest stock market
stock prices ABCL
premarket after hours
ticker ABCL
fair value insiders trading